IMC Chicago’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7M Buy
101,900
+38,300
+60% +$2.18M ﹤0.01% 1828
2026
Q1
$4.08M Sell
63,600
-15,800
-20% -$1.44M ﹤0.01% 1960
2025
Q4
$10.3M Sell
79,400
-16,500
-17% -$2.26M ﹤0.01% 1199
2025
Q3
$10.3M Sell
95,900
-51,800
-35% -$5.64M ﹤0.01% 1129
2025
Q2
$13.6M Buy
147,700
+125,200
+556% +$9.83M 0.01% 871
2025
Q1
$1.99M Buy
22,500
+12,300
+121% +$1.07M ﹤0.01% 1803
2024
Q4
$784K Buy
+10,200
New +$712K ﹤0.01% 2507

Other funds holding WGS

IMC Chicago's WGS Position: Q2 2026 in Review

IMC Chicago increased its GeneDx Holdings (WGS) stake by 176% in Q2 2026, buying an estimated $463K and bringing the position to 12,794 shares worth $878K. The position accounts for ﹤0.01% of the portfolio, ranked #4014.

IMC Chicago first reported a position in WGS in Q1 2026 and has held it in 2 quarters since. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • IMC Chicago held 12,794 shares of GeneDx Holdings worth $878K as of Q2 2026.
  • IMC Chicago bought 8,151 GeneDx Holdings shares in Q2 2026, an estimated $463K.
  • GeneDx Holdings made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4014 holding.
  • IMC Chicago first reported a position in GeneDx Holdings in Q1 2026 and has held it in 2 quarters since.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.